|07/30/15||Amgen Announces Appointment Of Fred Hassan To Board Of Directors|
|THOUSAND OAKS, Calif., July 30, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of Fred Hassan, partner and managing director of Warburg Pincus LLC, to the Amgen Board of Directors.
"We are pleased to welcome Fred Hassan and the deep, global experience he brings in the biopharmaceuticals sector to the Amgen Board," said Robert A. Bradway, chairman and chief executive officer of Amgen. "Fred's breadth of operational expertise and commitment to innovation will serve A... |
|07/30/15||Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57|
|Second Quarter 2015 GAAP EPS Increased 7 Percent to $2.15
2015 Total Revenues and Adjusted EPS Guidance Increased to $21.1-$21.4 Billion and $9.55-$9.80, Respectively
THOUSAND OAKS, Calif., July 30, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2015. Key results include:
Total revenues increased 4 percent versus the second quarter of 2014 to $5,370 million, with 6 percent product sales growth driven primarily by Enbrel® (etanerc... |
|07/28/15||Amgen Announces 2015 Third Quarter Dividend|
|THOUSAND OAKS, Calif., July 28, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) announced that its Board of Directors today declared a $0.79 per share dividend for the third quarter of 2015. The dividend will be paid on Sept. 8, 2015, to all stockholders of record as of the close of business on Aug. 17, 2015.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human t... |
|07/27/15||Amgen Announces Webcast of 2015 Second Quarter Financial Results|
|THOUSAND OAKS, Calif., July 27, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Thursday, July 30, 2015, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 2 p.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.
Live audio of the conf... |